FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
about
The ubiquitin-like protein FAT10 mediates NF-kappaB activationInvestigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathwaysN-octanoyl dopamine inhibits the expression of a subset of κB regulated genes: potential role of p65 Ser276 phosphorylationAltered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system.Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis.The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomesThe inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathwayUbiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery.Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.Diubiquitin (Ubd) is a susceptibility gene for virus-triggered autoimmune diabetes in ratsFAT10, a gene up-regulated in various cancers, is cell-cycle regulated.FAT10 modifies p53 and upregulates its transcriptional activity.Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins.FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination.Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity.Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platformFAT10 protects cardiac myocytes against apoptosis.FAT10 knock out mice livers fail to develop Mallory-Denk bodies in the DDC mouse modelProfiling of ubiquitin-like modifications reveals features of mitotic control.FAT10 is associated with the malignancy and drug resistance of non-small-cell lung cancerGenome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)).Orthogonal ubiquitin transfer identifies ubiquitination substrates under differential control by the two ubiquitin activating enzymes.Extended lifespan and reduced adiposity in mice lacking the FAT10 gene.Ubiquitin and ubiquitin-like proteins in cardiac disease and protection.FAT10 protein binds to polyglutamine proteins and modulates their solubility.FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.FAT10: a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy.Comparison of the effects of 40% oxygen and two atmospheric absolute air pressure conditions on stress-induced premature senescence of normal human diploid fibroblasts.The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation.Alcoholic liver disease - Hepatocellular carcinoma transformation.As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.Increased expression of FAT10 is correlated with progression and prognosis of human glioma.The non-canonical ubiquitin activating enzyme UBA6 suppresses epithelial-mesenchymal transition of mammary epithelial cells.Knockdown of ubiquitin D inhibits adipogenesis during the differentiation of porcine intramuscular and subcutaneous preadipocytes.UBD modifies APOL1-induced kidney disease risk.Ubiquitin‑like protein FAT10 regulates DNA damage repair via modification of proliferating cell nuclear antigen.
P2860
Q24328851-F5EE3B63-1601-4E40-A682-51C6CCF15AE4Q24337322-62E3FCA6-A558-4A8E-8170-7D18FF75389AQ27011543-C31F03CC-5DC0-4EE6-95AE-9018A2366E54Q28536426-62C042E1-D8EC-4886-AFC7-A3B070DEF871Q28591808-19F0CA05-EDA6-4AE4-BD66-A8A13A774332Q33868663-663F4CC5-50AE-4A1C-BE69-D6D4670BE65EQ33977054-C7E61FBC-9B3E-49D9-A269-0074CD38A2A8Q34162616-518D113D-36E2-4EA2-BBBC-0F5E019EDF70Q34250198-E991C59F-9122-4761-9620-996FE2B40FCEQ34467024-C2BC5808-251B-4478-AF69-912DC1D18837Q34660693-1D2982DD-F6A7-4061-B7FC-8B970D18C1D2Q35039785-3F9E9E8F-4A8A-48EF-A400-52DF65FD8BDCQ35097418-77737354-9605-4526-948A-C3C7DCD551FCQ35151521-C660CC1E-57E0-41E2-BDCA-5DDF5A91E037Q35642892-03648728-35A2-4A26-B588-000A43900B04Q35973306-5EA6FC70-D8BC-4981-9B50-CCC6E6A1C04FQ36707766-F7DEF5DB-F531-445B-92B0-436E00F64A16Q36823747-CD9725EA-FBB9-4D5B-9B71-C061E1A41625Q36972848-C94607E4-10CA-4DD8-BBE7-FA88309B3A8DQ37011725-F1A42ED1-4398-483A-A12A-71D984C2011BQ37122789-A171C695-2420-494F-AA50-9850F0B3FAE8Q37316075-05038B3A-783F-42DB-854E-F315C86E71FCQ37622535-63DEBA22-74BC-4FC0-898B-E2D4E01C2A32Q37702092-960DD82B-07F6-4B76-BDE8-982258E3A438Q38663141-41CBA09C-6600-4024-B147-E9B688798EFFQ38676071-C4454C96-9596-48C7-91A6-E5676C943FF2Q39044717-068A08DD-D95B-4E34-9004-448498A8007FQ39804433-F8615F99-7267-4E01-91D6-FF1DB2014A5EQ42040677-B63B6E00-E87C-4A23-8C31-C549E106D473Q42110703-FDCE13DC-728F-41C3-948B-63531693F5FEQ42201909-39D8A43C-9948-44B2-B5AC-77254CE782B4Q42256936-5675B9F4-CA0A-450C-A83B-6EA513091ECFQ46137258-AB9AE92A-5BD5-49AC-A023-A403A8081E13Q47141361-B87DD09D-0C1F-48A7-85B8-760805422192Q48242883-5B9939B7-4066-4592-AAEB-A07BAAF72846Q52659610-B4136C70-734E-47E0-856A-4024DCBEDF8DQ55191335-019CE7BF-8EF5-4CD6-B5A3-4BAED7955F42
P2860
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
description
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Juli 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/07/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/07/01)
@nl
наукова стаття, опублікована в липні 2006
@uk
مقالة علمية (نشرت في يوليو 2006)
@ar
name
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@ast
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@en
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@nl
type
label
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@ast
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@en
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@nl
prefLabel
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@ast
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@en
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@nl
P2093
P2860
P3181
P356
P1476
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences
@en
P2093
Allon Canaan
Carmen J Booth
Elizabeth Eynon
Katrina Castille
Naohiko Kohya
Richard Flavell
Serwa L Gamfi
Sherman M Weissman
Xiaofeng Yu
P2860
P304
P3181
P356
10.1128/MCB.00966-05
P407
P50
P577
2006-07-01T00:00:00Z